John Vavricka

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
31 Jan 25	AVIR Atea Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	3.06	11,517	35.24 k	52,081
31 Jan 25	AVIR Atea Pharmaceuticals	Common Stock	Grant	Acquire A	No	No	0	8,750	0.00	63,598
31 Jan 25	AVIR Atea Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	0	33,333	0.00	54,848
31 Jan 25	AVIR Atea Pharmaceuticals	Stock Option Common Stock	Grant	Acquire A	No	No	3.06	132,800	406.37 k	132,800
31 Jan 25	AVIR Atea Pharmaceuticals	RSU Common Stock	Grant	Acquire A	No	No	0	8,750	0.00	8,750
31 Jan 25	AVIR Atea Pharmaceuticals	RSU Common Stock	Option exercise	Dispose M	No	No	0	33,333	0.00	33,333
1 Feb 24	AVIR Atea Pharmaceuticals	Common Stock	Sell	Dispose S	No	Yes	3.843	11,819	45.42 k	21,515
31 Jan 24	AVIR Atea Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	0	33,334	0.00	33,334
31 Jan 24	AVIR Atea Pharmaceuticals	Stock Option Common Stock	Grant	Acquire A	No	No	4.16	132,800	552.45 k	132,800
31 Jan 24	AVIR Atea Pharmaceuticals	RSU Common Stock	Option exercise	Dispose M	No	No	0	33,334	0.00	66,666

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.